PMID- 37074369
OWN - NLM
STAT- MEDLINE
DCOM- 20230428
LR  - 20230428
IS  - 2731-7153 (Electronic)
IS  - 2731-7145 (Linking)
VI  - 52
IP  - 5
DP  - 2023 May
TI  - [Infiltration therapies for lateral epicondylopathy].
PG  - 379-386
LID - 10.1007/s00132-023-04371-9 [doi]
AB  - The therapy of the lateral epicondylopathy (tennis elbow) includes drug injection 
      into the extensor tendon insertion in chronic cases. The choice of medication and 
      the type of injection is decisive for the success of therapy. Furthermore, 
      accurate application is indispensable for therapy success (e.g. peppering 
      injection technique, ultrasound-supported injection technique). Corticosteroid 
      injection is often associated with short-term success, so that other options have 
      found their way into everyday practice. Objectification of treatment success is 
      usually defined by Patient-Reported Outcome Measurements (PROM). With the 
      introduction of Minimal Clinically Important Differences (MCID), statistically 
      significant results are put into perspective in terms of clinical significance. 
      Therapy for lateral epicondylopathy was considered effective if the mean 
      difference in score results between baseline and follow-up exceeded 1.5 points 
      for the Visual Analogue Scale (VAS), 16 points for Disabilities of Arm, Shoulder 
      and Hand Score (DASH), 11 points for Patient-Rated Tennis Elbow Evaluation 
      (PRTEE), and 15 points for Mayo Elbow Performance Score (MEPS). However, the 
      effectiveness must still be critically questioned according to meta-analytical 
      evaluations, in which healing within 12 months was found in 90% of the cases of 
      untreated chronic tennis elbow in the placebo groups. The use of substances, such 
      as Traumeel (Biologische Heilmittel Heel GmbH, Baden-Baden, Germany), hyaluronic 
      acid, botulinum toxin, platelet rich plasma (PRP), autologous blood or 
      polidocanol, are based on various mechanisms. In particular, the use of PRP or 
      autologous blood for the treatment of musculotendinous and degenerative articular 
      pathologies has become popular, although the studies regarding effectiveness are 
      inconsistent. PRP can be divided into leukocyte-rich (LR-PRP) and leukocyte-poor 
      plasma (LP-PRP) according to its preparation. In contrast to LP-PRP, LR-PRP 
      incorporates the middle and intermediate layers, but there is no standardized 
      preparation described in the literature. Conclusive data regarding effective 
      efficacy are still pending.
CI  - (c) 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, 
      ein Teil von Springer Nature.
FAU - Thiele, Kathi
AU  - Thiele K
AD  - Centrum fur Muskuloskeletale Chirurgie, Charite Universitatsmedizin Berlin, 
      Augustenburger Platz 1, 13353, Berlin, Deutschland. kathi.thiele@charite.de.
AD  - Auguste Viktoria Krankenhaus, Klinik fur Schulterchirurgie, Rubensstrasse 125, 
      Berlin, Deutschland. kathi.thiele@charite.de.
FAU - Unmann, Annemarie
AU  - Unmann A
AD  - Centrum fur Muskuloskeletale Chirurgie, Charite Universitatsmedizin Berlin, 
      Augustenburger Platz 1, 13353, Berlin, Deutschland.
AD  - LKH Feldbach, Feldbach, Osterreich.
FAU - Akgun, Doruk
AU  - Akgun D
AD  - Centrum fur Muskuloskeletale Chirurgie, Charite Universitatsmedizin Berlin, 
      Augustenburger Platz 1, 13353, Berlin, Deutschland.
FAU - Schoch, Christian
AU  - Schoch C
AD  - St. Vinzenz Klinik Pfronten, Pfronten, Deutschland.
FAU - Geyer, Stephanie
AU  - Geyer S
AD  - St. Vinzenz Klinik Pfronten, Pfronten, Deutschland.
AD  - Klinikum rechts der Isar, Munchen, Deutschland.
FAU - Thiele, Hildtrud
AU  - Thiele H
AD  - Privatpraxis Thiele, Berlin, Deutschland.
FAU - Mader, Konrad
AU  - Mader K
AD  - Universitatsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.
FAU - Siebenlist, Sebastian
AU  - Siebenlist S
AD  - Klinikum rechts der Isar, Munchen, Deutschland.
LA  - ger
PT  - English Abstract
PT  - Journal Article
PT  - Review
TT  - Infiltrationstherapien am Ellenbogengelenk bei Epicondylopathia humeri radialis.
DEP - 20230419
PL  - Germany
TA  - Orthopadie (Heidelb)
JT  - Orthopadie (Heidelberg, Germany)
JID - 9918384887206676
RN  - 0 (Adrenal Cortex Hormones)
SB  - IM
MH  - Humans
MH  - *Tennis Elbow/therapy
MH  - Adrenal Cortex Hormones
MH  - Treatment Outcome
MH  - Injections
MH  - Pain Measurement
OTO - NOTNLM
OT  - Corticosteroids
OT  - Hyaluronic acid
OT  - Platelet-rich plasma
OT  - Tennis elbow
OT  - Ultrasonography
EDAT- 2023/04/19 12:42
MHDA- 2023/04/28 06:42
CRDT- 2023/04/19 11:12
PHST- 2023/03/13 00:00 [accepted]
PHST- 2023/04/28 06:42 [medline]
PHST- 2023/04/19 12:42 [pubmed]
PHST- 2023/04/19 11:12 [entrez]
AID - 10.1007/s00132-023-04371-9 [pii]
AID - 10.1007/s00132-023-04371-9 [doi]
PST - ppublish
SO  - Orthopadie (Heidelb). 2023 May;52(5):379-386. doi: 10.1007/s00132-023-04371-9. 
      Epub 2023 Apr 19.